Published online before print October 17, 2002, doi: 10.1161/01.ATV.0000042230.26207.D2
© 2002 American Heart Association, Inc.
Thrombosis |
Increased Platelet-Collagen Interaction Associated With Double Homozygosity for Receptor Polymorphisms of Platelet GPIa and GPIIIa
From the Department of Internal Medicine (R.L.), Helsinki University Central Hospital, Wihuri Research Institute Helsinki, Finland; and the Department of Medicine (J.H.B., L.P., S.P., H.R.S., M.B.), Laboratory for Thrombosis Research, Kantonsspital Baden, Switzerland.
Correspondence to J.H. Beer, MD, Department of Medicine, Kantonsspital Baden, 5404 Baden, Switzerland. E-mail hansjuerg.beer{at}ksb.ch
Objective— There is considerable controversy regarding the clinical role of the single-nucleotide polymorphisms (SNPs) of the platelet glycoprotein receptor GPIa C807T and the PlA1/A2 of GPIIIa as cardiovascular risk factors. We hypothesized that two combined SNPs in their homozygous prothrombotic forms could clarify their pathophysiological impact.
Methods and Results— We identified a family with a striking history of premature cardiovascular events and a high frequency of the prothrombotic form of the two SNPs. From this family, the platelets of a healthy, 27-year-old propositus with this double homozygosity were compared with three matched male neutral gene variant controls. The propositus had shortened PFA-100 closure times and an increased platelet aggregation response to collagen. Platelet deposition to collagen was augmented under the blood flow conditions of a high shear rate model (1600 s-1). Platelet adhesion on collagen monomers was induced in a static system, leading to the promotion of subsequent procoagulant activity.
Conclusions— The combined homozygous prothrombotic SNPs of GPIa and GPIIIa are associated with an increased platelet–collagen interaction and procoagulant activity that can be readily demonstrated in several independent systems. Our patient may serve as a useful model for the functional consequences of two combined, potentially procoagulant, platelet SNPs.
Key Words: platelet • receptor • myocardial infarction • collagen • polymorphism
This article has been cited by other articles:
 |
|
 |
|
  S Jimenez, D Tassies, G Espinosa, A Garcia-Criado, J Plaza, J Monteagudo, R Cervera, and J C Reverter Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus Ann Rheum Dis, June 1, 2008; 67(6): 835 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Antoniades, D. Tousoulis, C. Vasiliadou, E. Stefanadi, K. Marinou, and C. Stefanadis Genetic Polymorphisms of Platelet Glycoprotein Ia and the Risk for Premature Myocardial Infarction: Effects on the Release of sCD40L During the Acute Phase of Premature Myocardial Infarction J. Am. Coll. Cardiol., May 16, 2006; 47(10): 1959 - 1966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Wang, D. L. Bhatt, and E. J. Topol Aspirin and clopidogrel resistance: an emerging clinical entity Eur. Heart J., March 2, 2006; 27(6): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Bhatt Aspirin resistance: more than just a laboratory curiosity J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1127 - 1129. [Full Text] [PDF]
|
|
|
|
|
|
A. Lepantalo, K. S Virtanen, J. Heikkila, U. Wartiovaara, and R. Lassila Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions Eur. Heart J., March 2, 2004; 25(6): 476 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Porto, A. M. Leone, A. Sciahbasi, F. Andreotti, J. H. Beer, L. Pontiggia, and R. Lassila Increased Platelet Reactivity Due to Platelet Receptor Polymporphisms? Not in the Real World * Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1703 - 1704. [Full Text] [PDF]
|
|